Literature DB >> 27390760

X-gal Staining on Adult Mouse Brain Sections.

Hiroshi Kokubu1, Janghoo Lim1.   

Abstract

Knowing expression patterns of given proteins is very important to understand their functions. Immunostaining analysis with specific antibodies is commonly used to identify cells or tissues expressing proteins of interest. Although this technique is regularly used, it requires high quality of specific antibodies and there is no good quality of antibody available for certain proteins. Alternatively, X-gal staining is also used to analyze protein expression pattern. It is simple and routinely used to detect expression pattern of any proteins of interest in vivo. In this method, genetically modified animals that express beta-galactosidase under the control of certain regulatory elements will be used to reveal the expression pattern of proteins that use the same regulatory elements.

Entities:  

Year:  2014        PMID: 27390760      PMCID: PMC4932900          DOI: 10.21769/bioprotoc.1064

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  1 in total

1.  Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Tiffany W Todd; Juliette J Kahle; Soeun Kim; Ronald Richman; Karthik Chirala; Harry T Orr; Huda Y Zoghbi; Janghoo Lim
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

  1 in total
  2 in total

1.  Regulation of prefrontal patterning and connectivity by retinoic acid.

Authors:  Mikihito Shibata; Kartik Pattabiraman; Belen Lorente-Galdos; David Andrijevic; Suel-Kee Kim; Navjot Kaur; Sydney K Muchnik; Xiaojun Xing; Gabriel Santpere; Andre M M Sousa; Nenad Sestan
Journal:  Nature       Date:  2021-10-01       Impact factor: 69.504

2.  Endophilin A1 Promotes Actin Polymerization in Dendritic Spines Required for Synaptic Potentiation.

Authors:  Yanrui Yang; Jiang Chen; Zhenzhen Guo; Shikun Deng; Xiangyang Du; Shaoxia Zhu; Chang Ye; Yun S Shi; Jia-Jia Liu
Journal:  Front Mol Neurosci       Date:  2018-05-28       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.